Skip to main content
Caplight Logo









Myota Health

Myota Health

Private
LondonConsumer & Commercehttps://myotahealth.com/

Last Round

Series A

Jun 22, 2026

Total Funding Raised

$4.5M

Company Overview

Myota Health operates in Consumer & Commerce and is based in London. Its latest recorded funding round was a Series A round in June 2026.

Myota Health is a biotechnology company that develops and markets clinically studied, patented prebiotic fibre blends designed to support gut microbiome health and diversity.

Sector

Consumer & Commerce

Verticals

D2C Brands, Biotechnology, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Myota Health Comparables

Compare Myota Health with similar companies based on industry and business-model similarity.

Myota Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Floré
79%
Ombre
77%
Seed Health
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Myota Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 22, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Kat Stennett

Co-founder & CEO

Founding Team

For institutional investors. Book with your work email.

Myota Health Investors

Notable investors and investment history

Myota Health investors
InvestorRounds
PeakBridgeSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 11, 2025

    Grew 50% QoQ from 6 to 9 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Myota Health Filings

Explore SEC and related filing metadata, where available.

Myota Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Myota Health's valuation, stock price, and market status.

Is Myota Health a public or private company?

Myota Health is a private company.

What is the current stock price of Myota Health?

Myota Health is a private company, so its shares have no public market price. Caplight tracks Myota Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Myota Health worth (valuation)?

Valuation information for Myota Health is not publicly available.

Can I buy Myota Health stock?

Myota Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Myota Health's last funding round?

Myota Health's most recent funding round was Series A on June 22, 2026.

Who are the main investors in Myota Health?

Key investors in Myota Health include PeakBridge.

Will Myota Health IPO soon?

No public IPO plans have been announced for Myota Health.

How can I track Myota Health secondary market activity?

Caplight tracks bids, offers, and trades in Myota Health's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range10
Year Founded2019
Last FundingJun 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?